Distinction of the LifeSciences Department in TIER 2 of the Legal 500 EMEA

Tout Corporate life LexCase events Life Science Press release

[INTERNATIONAL] LexCase joins the Legus International network

13/09/2022

[INTERNATIONAL] LexCase joins the Legus International network

13/09/2022

[PUBLICATION] The life Sciences department signs the France chapter of “Healthcare Enforcement & Litigation 2023”.

30/08/2022

[PUBLICATION] The life Sciences department signs the France chapter of “Healthcare Enforcement & Litigation 2023”.

30/08/2022

[DISTINCTION] Best Lawyers 2023 LexCase distinguished in 7 catégories !

23/06/2022

[DISTINCTION] Best Lawyers 2023 LexCase distinguished in 7 catégories !

23/06/2022

[WELCOME] Aurélie POULIGUEN joins LexCase as a partner, accompanied by Alice ANGELOT

16/05/2022

[WELCOME] Aurélie POULIGUEN joins LexCase as a partner, accompanied by Alice ANGELOT

16/05/2022

Distinction of the LifeSciences Department in TIER 2 of the Legal 500 EMEA

14/04/2022

Distinction of the LifeSciences Department in TIER 2 of the Legal 500 EMEA

14/04/2022

[PUBLICATION] Lexology – Getting the Deal Through : « Healthcare Enforcement & Litigation »

06/10/2021

[PUBLICATION] Lexology – Getting the Deal Through : « Healthcare Enforcement & Litigation »

06/10/2021

[INTERNSHIP OFFER] Immigration & international mobility

05/10/2021

[INTERNSHIP OFFER] Immigration & international mobility

05/10/2021

[PUBLIC LAW] The end of framework agreements without maximum

22/09/2021

[PUBLIC LAW] The end of framework agreements without maximum

22/09/2021

Distinction of the LifeSciences Department in TIER 2 of the Legal 500 EMEA

14/04/2022 , 12h26

The LifeSciences team distinguished, once again, by The Legal 500 (Legalease) en TIER 2 en Industry Focus: Healthcare and LifeSciences.

Congratulations to the team and a huge thank you to our clients for their testimonials.

“The quality of the legal analysis, the availability of the team, the speed of execution, the pragmatic nature of the analyses, the command of English, the teamwork stand out.”

“Excellent knowledge of pharmaceutical regulations and regulatory subtleties. Excellent ability to advise by weighing the benefits and risks and being objective. Strength of proposal.”